KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Free Cash Flow (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 53.69%
Dec 31, 2025 -77.38%
Sep 30, 2025 122.29%
Jun 30, 2025 95.00%
Mar 31, 2025 -77.73%
Dec 31, 2024 32.77%
Sep 30, 2024 49.21%
Jun 30, 2024 383.88%
Mar 31, 2024 58.82%
Dec 31, 2023 -88.50%
Sep 30, 2023 -34.55%
Jun 30, 2023 433.06%
Mar 31, 2023 -68.82%
Dec 31, 2022 -18.06%
Sep 30, 2022 67.34%
Jun 30, 2022 -14.69%
Mar 31, 2022 -21.70%
Dec 31, 2021 15.85%
Sep 30, 2021 24.63%
Jun 30, 2021 -9.91%
Mar 31, 2021 -2.12%
Dec 31, 2020 -38.76%
Sep 30, 2020 20.45%
Jun 30, 2020 34.74%
Mar 31, 2020 -14.36%
Dec 31, 2019 -27.47%
Sep 30, 2019 152.52%
Jun 30, 2019 -26.55%
Mar 31, 2019 -41.76%
Dec 31, 2018 -4.29%
Sep 30, 2018 61.98%
Jun 30, 2018 -25.54%
Mar 31, 2018 -10.04%
Dec 31, 2017 -13.26%
Sep 30, 2017 53.95%
Jun 30, 2017 -3.43%
Mar 31, 2017 -22.83%
Dec 31, 2016 15.15%
Sep 30, 2016 0.24%
Jun 30, 2016 41.50%
Mar 31, 2016 -5.84%
Dec 31, 2015 -32.17%
Sep 30, 2015 -12.60%
Jun 30, 2015 131.01%
Mar 31, 2015 -48.31%
Dec 31, 2014 2.64%
Sep 30, 2014 25.17%
Jun 30, 2014 111.75%
Mar 31, 2014 -40.64%
Dec 31, 2013 0.12%
Sep 30, 2013 13.25%
Jun 30, 2013 61.73%
Mar 31, 2013 45.59%
Dec 31, 2012 -60.52%
Sep 30, 2012 -29.64%
Jun 30, 2012 166.06%
Mar 31, 2012 -39.12%
Dec 31, 2011 60.19%
Sep 30, 2011 -39.92%
Jun 30, 2011 51.94%
Mar 31, 2011 -49.07%
Dec 31, 2010 55.40%
Sep 30, 2010 -15.28%
Jun 30, 2010 69.35%
Mar 31, 2010 -51.22%
Dec 31, 2009 -9.00%
Sep 30, 2009 19.81%
Jun 30, 2009 107.55%